Although some receptors were differentially expressed between ES-3 B2M KO-NKs and ES-3-NKs, the cytotoxicity against all cancer cell lines (K562, A2780 cis, and SKOV3) was similar (Figure 5j). This evidence concerns the gene B2M and cancer.